Evidence map›Paper›PMID 32363294›Full record

ArticleACS omega2020

New MOF/COF Hybrid as a Robust Adsorbent for Simultaneous Removal of Auramine O and Rhodamine B Dyes.

Maryam Firoozi, Zahra Rafiee, Kheibar Dashtian

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maryam FirooziDepartment of Chemistry, Yasouj University, Yasouj 75918-74831, Islamic Republic of Iran.
Zahra RafieeDepartment of Chemistry, Yasouj University, Yasouj 75918-74831, Islamic Republic of Iran.
Kheibar DashtianDepartment of Chemistry, Yasouj University, Yasouj 75918-74831, Islamic Republic of Iran.
Yasouj University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, by hybridization of zinc-based metal-organic framework-5 (MOF-5) and melamine-terephthaldehyde-based intergrade two-dimensional π-conjugated covalent organic framework (COF), a novel MOF-5/COF (M5C) hybrid material was prepared and characterized by Fourier transform infrared, field emission scanning electron microscopy, X-ray diffraction, and thermogravimetric analysis. MOF-5 has a well-defined cubic structure, and the proposed COF has an orderly and spherical nanosize shape. The prepared MOF-5/COF was applied as an effective adsorbent for rapid and high-efficient simultaneous removal of auramine O (AO) and rhodamine B (RB) cationic dyes via electrostatic, H-bonding, Lewis acid-base interactions, and π-π stacking from aqueous solution. The effect of experimental parameters such as pH, M5C mass, contact time, and AO and RB dyes concentration was investigated for removal efficiency and optimized. The M5C adsorbent showed an adsorption capacity of 17.95 and 16.18 mg/g for AO and RB dyes, respectively, at pH 9.5. The adsorption study of AO and RB dyes by M5C comprises both isotherm and kinetic studies. The equilibrium adsorption data followed by Langmuir isotherm and the adsorption kinetic process were found to be a pseudo-second-order model. The robustness adsorption efficiency of MOF/COF hybrids can be attributed to the formation of amide bonds between COF and MOFs, which improve the stability of the adsorbent.

Identifiers

PMID32363294
PMCPMC7191862
OpenAlexW3015687294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.